retatrutide weight loss results clinical trial Results: 24% in 48 Weeks First Retatrutide phase 3 data,

Acar A, Erba O

p = 0.001) implying that ghrelin decrease was related to glucose control improvement, which is consistent with reported hyperglycemic and insulin resistance promoting effects of acyl ghrelin [35]

In preclinical models, comparison of cotadutide, a glucagon/GLP-1 dual RA, and liraglutide demonstrated superior reduction of hepatic de novo lipogenesis and enhancement of hepatocyte mitochondrial oxidative capacity (similar to levels stimulated by glucagon mono-agonismsuggesting restoration of mitochondrial function is a glucagon-specific benefit) [39]

Roy B, Pattanaik AK, Das J, et al

Most of the time, the issue is either incorrect dosing, a protocol not matched to their specific labs, or a compound thats not the right fit for their goals